on-alcoholic Fatty Liver Disease Dietary Trial

Not Applicable

• Conditions: on-alcoholic fatty liver disease; Presence of cardiovascular risk factors; Non-alcoholic fatty liver disease; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12612000841875
• Lead Sponsor: Catherine Properzi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

NAFLD diagnosis with hepatic steatosis (>5.5% as determined by MRS).
Weight stability; variation of <5% within the preceding 3-month period.

Exclusion Criteria

Secondary causes of NAFLD.
Other causes of liver disease deficiency.
Type 2 diabetes mellitus with A1C >8.5% or requiring insulin.
Mean alcohol consumption > 20 g/day or 140 g per week in females, >30 g/day or 210 g/week in males.
Decompensated liver cirrhosis.
Renal failure.
Malignancy aside from skin cancer.
Current tobacco use.
Conditions preventing required assessment or informed consent.
Use of weight loss medications.
Lipid lowering medications.
Fish oil supplement use within the past 3 months.
Pregnancy or lactation.
Patients unwilling/unable to maintain stable body weight and/or comply with specifically prescribed dietary intake.

Study & Design

• Study Type: Interventional
• Study Design: Not specified